Department of Defense awards DxDiscovery/University of South Alabama $1M Phase II SBIR
DxDiscovery is continuing efforts to develop medical countermeasures against melioidosis and glanders. These diseases are caused by Burkholderia pseudomallei and Burkholderia mallei, respectively. B. mallei infections are rare, however, B. pseudoamallei infections are a significant cause of morbidity and mortality in southeast Asia.Read More
Point of Care immunoassay for early diagnosis of pertussis awarded.
National Institutes of Health , National Institute of Allergy and Infectious Disease award number R43AI109891 was awarded to Principal Scientist Amanda Burnham-Marusich and Thomas Kozel for development of a point of care immunoassay for early diagnosis of pertussis on June, 1st 2014.Read More